HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

Abstract Background HER2 (ERBB2 or HER2/neu) is a tyrosine-kinase increasing cell proliferation. Overexpression/amplification of HER2 is correlated with worse prognosis in solid malignancies. Consequently, HER2 targeting is established in breast and upper gastrointestinal tract cancer. There are con...

Full description

Bibliographic Details
Main Authors: Patrick Sven Plum, Florian Gebauer, Max Krämer, Hakan Alakus, Felix Berlth, Seung-Hun Chon, Lars Schiffmann, Thomas Zander, Reinhard Büttner, Arnulf Heinrich Hölscher, Christiane Josephine Bruns, Alexander Quaas, Heike Loeser
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
HER2/neu (ERBB2)
Esophageal adenocarcinoma (EAC)
Prognosis
Immunohistochemistry
Tissue microarray (TMA)
Fluorescence-in-situ-hybridization (FISH)
Online Access:http://link.springer.com/article/10.1186/s12885-018-5242-4

Internet

http://link.springer.com/article/10.1186/s12885-018-5242-4

Similar Items